Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
3.820
+0.010 (0.26%)
Jun 24, 2026, 4:00 PM EDT - Market closed
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of $144.12 million as of June 24, 2026. Its market cap has increased by 8.65% in one year.
Market Cap
144.12M
Enterprise Value
51.24M
1-Year Change
8.65%
Ranking
Category
Stock Price
$3.82
Market Cap Chart
Since the IPO on June 16, 2021, Molecular Partners AG's market cap has decreased from $683.35M to $144.12M, a decrease of -78.91%. That is a compound annual growth rate of -26.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 144.12M | -10.00% |
| Dec 30, 2025 | 160.13M | -2.96% |
| Dec 30, 2024 | 165.01M | 22.94% |
| Dec 29, 2023 | 134.22M | -38.09% |
| Dec 30, 2022 | 216.81M | -65.56% |
| Dec 30, 2021 | 629.47M | -7.89% |
| Jun 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tenaya Therapeutics | 151.90M |
| Spruce Biosciences | 150.55M |
| Cognition Therapeutics | 150.36M |
| Enlivex | 150.17M |
| Tiziana Life Sciences | 148.70M |
| Alpha Cognition | 147.19M |
| NRx Pharmaceuticals | 141.16M |
| ADC Therapeutics | 138.64M |